Is prostaglandin fever mediated by the presynaptic release of hypothalamic 5-HT or norepinephrine? 1976

R D Myers, and M B Waller

An array of guide tubes to accommodate concentric push-pull cannulae was implanted chronically within the diencephalon of the rhesus or other species of macaque monkey which was accustomed to a primate chair. Colonic and skin temperatures were monitored continuously during each experiment in which a circumscribed site in the monkey's hypothalamus had been labelled by microinjection of 50-100 muCi serotonin (3H-5-HT) or 50-100 muCi or norepinephrine (3H-NE). Consecutive push-pull perfusions with an artificial CSF were carried out for 10 min at a rate of 50 mul/min at 20 min intervals. Under the control condition, a declining washout curve of radioactivity was obtained over 8-10 perfusions. Prostaglandin (PG) E1 in a concentration of 10-20 ng/min was added to the artificial CSF during the third and fifth successive perfusions. Nonlabelled PGE1 failed to exert a precise and consistent effect on the characteristic pattern of efflux of either tritiated 5-HT or NE from perfusion sites distributed widely throughout the hypothalamus and adjacent structures. However, in some experiments, an enhanced efflux of the indoleamine label did occur after the temperature had begun to rise following a perfusion with the PGE. In still other experiments, 15-20 muCi 3H-PGE1 was microinjected to label a perfusion site. Again the addition of either nonlabelled 5-HT or NE to the perfusion fluid produced an unreliable change or no alteration in the efflux of 3H-ge1 from sites in the anterior as well as other parts of the hypothalamus. These findings indicate that prostaglandin injected into the brain does not evoke hyperthemia by way of a pathological disturbance to the balance in the presynaptic release of 5-HT and NE within nerve endings in the rostral hypothalamus of the monkey. Conversely, neither 5-HT nor NE influences the prostaglandin activity within the hypothalamus, at least in so far as a functional change in the body temperature of the primate is concerned.

UI MeSH Term Description Entries
D007031 Hypothalamus Ventral part of the DIENCEPHALON extending from the region of the OPTIC CHIASM to the caudal border of the MAMMILLARY BODIES and forming the inferior and lateral walls of the THIRD VENTRICLE. Lamina Terminalis,Preoptico-Hypothalamic Area,Area, Preoptico-Hypothalamic,Areas, Preoptico-Hypothalamic,Preoptico Hypothalamic Area,Preoptico-Hypothalamic Areas
D008297 Male Males
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D011301 Preoptic Area Region of hypothalamus between the ANTERIOR COMMISSURE and OPTIC CHIASM. Area Preoptica,Lateral Preoptic Area,Medial Preoptic Area,Preoptic Nuclei,Area Preopticas,Area, Lateral Preoptic,Area, Medial Preoptic,Area, Preoptic,Areas, Lateral Preoptic,Areas, Medial Preoptic,Areas, Preoptic,Lateral Preoptic Areas,Medial Preoptic Areas,Nuclei, Preoptic,Nucleus, Preoptic,Preoptic Area, Lateral,Preoptic Area, Medial,Preoptic Areas,Preoptic Areas, Lateral,Preoptic Areas, Medial,Preoptic Nucleus,Preoptica, Area,Preopticas, Area
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D004027 Diencephalon The paired caudal parts of the PROSENCEPHALON from which the THALAMUS; HYPOTHALAMUS; EPITHALAMUS; and SUBTHALAMUS are derived. Interbrain,Interbrains
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005334 Fever An abnormal elevation of body temperature, usually as a result of a pathologic process. Pyrexia,Fevers,Pyrexias
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000882 Haplorhini A suborder of PRIMATES consisting of six families: CEBIDAE (some New World monkeys), ATELIDAE (some New World monkeys), CERCOPITHECIDAE (Old World monkeys), HYLOBATIDAE (gibbons and siamangs), CALLITRICHINAE (marmosets and tamarins), and HOMINIDAE (humans and great apes). Anthropoidea,Monkeys,Anthropoids,Monkey

Related Publications

R D Myers, and M B Waller
January 1986, Clinical neuropharmacology,
R D Myers, and M B Waller
May 2007, Neuroscience,
R D Myers, and M B Waller
January 1989, Psychopharmacology,
R D Myers, and M B Waller
June 1983, Science (New York, N.Y.),
R D Myers, and M B Waller
January 1989, Clinical and experimental hypertension. Part A, Theory and practice,
R D Myers, and M B Waller
March 1995, Life sciences,
R D Myers, and M B Waller
October 1989, Journal of neuroendocrinology,
R D Myers, and M B Waller
February 1985, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!